Visceral leishmaniasis

Gastroenterology Clinics of North America

Volumn 25, Issue 3, 1996, Pages 535-551

  Wilson, M E ^a   Streit, J A ^a  

^a UNIVERSITY OF IOWA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHOTERICIN B; ANTIMONY DERIVATIVE; PENTAMIDINE;

CLINICAL FEATURE; DRUG MONITORING; HEALTH CARE ACCESS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LIFE CYCLE; PARASITE CULTIVATION; REVIEW; SERODIAGNOSIS; SIDE EFFECT; VISCERAL LEISHMANIASIS;

EID: 0029837718     PISSN: 08898553     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0889-8553(05)70262-4     Document Type: Article

References (132)

1. A.A. Abdel-Hameed A.E. Harith I.M. Abdel-Rahim Potential of a direct agglutination test (DAT) for detection of visceral leishmaniasis in a known endemic area in Sudan Trop Med Parasit 40 1989 470
2. T. Aebischer Recurrent cutaneous leishmaniasis: A role for persistent parasites? Parasitol Today 10 1994 25
3. T. Aebischer S.F. Moody E. Handman Persistence of virulent Leishmania major in murine cutaneous leishmaniasis: A possible hazard for the host Infect Immunol 61 1993 220
4. L.C.C. Afonso T.M. Scharton L.Q. Vieira The adjuvant effect of interleukin-12 in a vaccine against Leishmania major Science 263 1994 235
5. J. Alvar Leishmaniasis and the AIDS co-infection: The Spanish example Parasitol Today 10 1994 160
6. J.A. Alvar J.A. Ballesteros R. Soler Mucocutaneous leishmaniasis due to Leishmania infantum: Biochemical characterization Am J Trop Med Hyg 43 1990 614
7. T.M. Andrade E.M. Carvalho H. Rocha Bacterial infections in patients with visceral leishmaniasis J Infect Dis 162 1990 1354
8. R.L. Anthony M. Grogl J.B. Sacci Rapid detection of Leishmania amastigotes in fluid aspirates and biopsies of human tissues Am J Trop Med Hyg 37 1987 271
9. R.W. Ashford P. Desjeux P. DeRaadt Estimation of population at risk of infection and number of cases of leishmaniasis Parasitol Today 8 1992 104
10. R.W. Ashford J. Seaman J. Schorscher Epidemic visceral leishmaniasis in southern Sudan: Identity and systematic position of the parasites from patients and vectors Trans R Soc Trop Med Hyg 86 1992 379
11. R. Badaro T.C. Jones E.M. Carvalho New perspectives on a subclinical form of visceral leishmaniasis J Infect Dis 154 1986 1003
12. R. Badaro T.C. Jones R. Lorenco A prospective study of visceral leishmaniasis in an endemic area of Brazil J Infect Dis 154 1986 639
13. R. Badaro Johnson W.D. Jr The role of interferon-gamma in the treatment of visceral and diffuse cutaneous leishmaniasis J Infect Dis 167 suppl 1 1993 S13
14. P. Bandyopadhyay D.K. Ghosh A. De Metacyclogenesis of Leishmania spp: Species-specific in vitro transformation, complement resistance, and cell surface carbohydrate and protein profiles J Parasitol 77 1991 411
15. Barbosa Junior A.A. Z.A. Andrade S.G. Reed The pathology of experimental visceral leishmaniasis in resistant and susceptible lines of inbred mice Brazilian J Med Res 20 1987 63
16. R.J. Baumann W.L. Hanson P.P. McCann Suppression of both antimony-susceptible and antimony-resistant Leishmania donovani by a Bis(Benzyl)Polyamine analog Antimicrob Agents Chemother 34 1990 722
17. T.H. Benderitter P. Casanova L. Nashkidachvili Glomerulonephritis in dogs with canine leishmaniasis Ann Trop Med Parasitol 82 1988 335
18. J.D. Berman Chemotherapy for leishmaniasis: Biochemical mechanisms, clinical efficacy and future strategies Rev Infect Dis 10 1988 560
19. J.M. Blackwell R.A.B. Ezekowitz M.B. Roberts Macrophage complement and lectin-like receptors bind Leishmania in the absence of serum J Exp Med 162 1985 324
20. C. Blank H. Fuchs K. Rappersberger Parasitism of epidermal Langerhans cells in experimental cutaneous leishmaniasis with Leishmania major J Infect Dis 167 1993 418
21. D.J. Bradley B.A. Taylor J. Blackwell Regulation of Leishmania populations within the host: III. Mapping of the locus controlling susceptibility to visceral leishmaniasis in the mouse Clin Exp Immunol 37 1979 7
22. Burns J.M. Jr W.G. Shreffler D.R. Benson Molecular characterization of a kinesin-related antigen of Leishmania chagasi that detects specific antibody in African and American visceral leishmaniasis Proc Natl Acad Sci USA 90 1993 775
23. E.M. Carvalho O. Bacellar A. Barral Antigen-specific immunosuppression in visceral leishmaniasis is cell mediated J Clin Invest 83 1989 860
24. E.M. Carvalho R. Badaro S.G. Reed Absence of gamma interferon and interleukin 2 production during active visceral leishmaniasis J Clin Invest 76 1985 2066
25. E.M. Carvalho A. Barral J.M.L. Costa Clinical and immunopathological aspects of disseminated cutaneous leishmaniasis Acta Trop (Basel) 56 1994 315
26. E.M. Carvalho A. Barral D. Pedral-Sampaio Immunologic markers of clinical evolution in children recently infected with Leishmania donovani chagasi J Infect Dis 165 1992 535
27. M. Castes M. Cabrera D. Trujillo T-cell subpopulations, expression of interleukin-2 receptor, and production of interleukin-2 and gamma interferon in human American cutaneous leishmaniasis J Clin Microbiol 26 1988 1207
28. B.J. Cerf T.C. Jones R. Badaro Malnutrition as a risk factor for severe visceral leishmaniasis J Infect Dis 156 1987 1030
29. Chang K.-P. Bray R.S. Leishmaniasis 1985 Elsevier New York
30. Chang K.-P. D. Fong R.S. Bray Biology of Leishmania and leishmaniasis Chang K.-P. Bray R.S. Leishmaniasis 1985 Elsevier New York 1
31. J.D. Chulay A.D.M. Bryceson Quantitation of amastigotes of Leishmania donovani in smears of splenic aspirates from patients with visceral leishmaniasis Am J Trop Med Hyg 32 1983 475
32. C.N. Chunge J. Owate H.O. Pamba Treatment of visceral leishmaniasis in Kenya by aminodisine alone or combined with sodium stibogluconate Trans Soc Trop Med Hyg 84 1990 221
33. F. Conceicao-Silva R.C.C. Dorea C. Pirmez Quantitative study of Leishmania braziliensis braziliensis reactive T cells in peripheral blood and in the lesions of patients with American mucocutaneous leishmaniasis Clin Exp Immunol 79 1990 221
34. Control of the leishmaniases WHO Technical Report Series 793 1990 25
35. J. Convit A. Rondon M. Ulrich Immunotherapy versus chemotherapy in localised cutaneous leishmaniasis Lancet 1 1987 401
36. A. Cooper H. Rosen J.M. Blackwell Monoclonal antibodies that recognize distinct epitopes of the macrophage type three complement receptor differ in their ability to inhibit binding of Leishmania promastigotes harvested at different phases of their growth cycle Immunology 65 1988 511
37. F. Coppola S. Recchia A. Ferrari Visceral leishmaniasis in AIDS with gastric involvement Gastrointest Endosc 38 1992 76
38. da Silva R. B.F. Hall K.A. Joiner CR1, the C3b receptor, mediates binding of infective Leishmania major metacyclic promastigotes to human macrophages J Immunol 143 1989 617
39. R.N. Davidson Di Martino L. L. Gradoni Liposomal amphotericin B (AmBisome) in Mediterranean visceral leishmaniasis: A multi-centre trial Q J Med 87 1994 75
40. De Beer P. A. Harith L.L. Deng A killing disease epidemic among displaced Sudanese population identified as visceral leishmaniasis Am J Trop Med Hyg 44 1991 283
41. De Bruijn M.H.L. D.C. Barker Diagnosis of New World leishmaniasis: Specific detection of species of the Leishmania braziliensis complex by amplification of kinetoplast DNA Acta Trop (Basel) 52 1992 45
42. C. Dye The epidemiology of visceral leishmaniasis in southern France: Classical tehory offers another explanation of the data Parasitology 96 1988 19
43. C. Dye R. Killick-Kendrick M.M. Vitutia Epidemiology of canine leishmaniasis: Prevalence, incidence and basic reproduction number calculated from a cross-sectional serological survey on the island of Gozo, Malta Parasitology 105 1992 35
44. El Harith A. A.H.J. Kolk J. Leeuwenburg Improvement of a Direct Agglutination Test for field studies of visceral leishmaniasis J Clin Microbiol 26 1988 1321
45. El Hassan A.M. M.S. Ali E.E. Zijlstra Post-kala-azar dermal leishmaniasis in the Sudan: Peripheral neural involvement Int J Dermatol 400 1992
46. El Hassan A.M. H.W. Ghalib E.E. Zijlstra Post kala-azar dermal leishmaniasis in the Sudan: Clinical features, pathology and treatment Trans R Soc Trop Med Hyg 86 1992 245
47. S.H. El-Safi W. Peters D.A. Evans Studies on the leishmaniases in the Sudan: 3. Clinical and parasitological studies on visceral and mucosal leishmaniasis Trans R Soc Trop Med Hyg 85 1991 465
48. A.H. Fairlamb A. Cerami Metabolism and functions of trypanothione in the kinetoplastida Annu Rev Microbiol 46 1992 695
49. J.L. Fernandez-Guerro J.M. Aguado L. Buzon Visceral leishmaniasis in immunocompromised hosts Am J Med 83 1987 1098
50. C. Fernandez-Miranda F. Colina J.M. Delgado Diffuse nodular regenerative hyperplasia of the liver associated with human immunodeficiency virus and visceral leishmaniasis Am J Gastroenterol 88 1993 433
51. E.D. Franke F.S. Wignall M.E. Cruz Efficacy and toxicity of sodium stibogluconate for mucosal leishmaniasis Ann Intern Med 113 1990 934
52. R.A. Gasser A.J. Magill C.N. Oster Pancreatitis induced by pentavalent antimonial agents during treatment of leishmaniasis Clin Infect Dis 18 1994 83
53. H.W. Ghalib M.R. Piuvezam Y.A.W. Skeiky Interleukin 10 production correlates with pathology in human Leishmania donovani infections J Clin Invest 92 1993 324
54. Grimaldi G. Jr R.B. Tesh Leishmaniases of the new world: Current concepts and implications for future research Clin Microbiol Rev 6 1993 230
55. Grimaldi G. Jr R.B. Tesh D. McMahon-Pratt A review of the geographic distribution and epidemiology of leishmaniasis in the New World Am J Trop Med Hyg 41 1989 687
56. M.A. Halim O. Alfurayh M.E. Kalin Successful treatment of visceral leishmaniasis with allopurinol plus ketoconazole in a renal transplant recipient after the occurrence of pancreatitis due to stibogluconate Clin Infect Dis 16 1993 397
57. F.P. Heinzel D.S. Schoenhaut R.M. Rerko Recombinant interleukin 12 cures mice infected with Leishmania major J Exp Med 177 1993 1505
58. B.L. Herwaldt J.D. Berman Recommendations for treating leishmaniasis with sodium stibogluconate (pentostam) and review of pertinent clinical studies Am J Trop Med Hyg 46 1992 296
59. J.L. Ho R. Badaro A. Schwartz Diminished in vitro production of interleukin-1 and tumor necrosis factor-α during acute visceral leishmaniasis and recovery after therapy J Infect Dis 165 1992 1094
60. B.J. Holaday Pompeu MM de L. T. Evans Correlates of Leishmania -specific immunity in the clinical spectrum of infection with Leishmania chagasi J Infect Dis 167 1993 411
61. J.A. Jernigan R.D. Pearson Chemotherapy of leishmaniasis, Chagas' disease and African trypanosomiasis Curr Opin Infect Dis 6 1993 794
62. S.M.B. Jeronimo R.M. Oliveira S. Mackay An urban outbreak of visceral leishmaniasis in Natal, Brazil Trans R Soc Trop Med Hyg 88 1994 386
63. C.L. Karp S.H. El-Safi T.A. Wynn In vivo cytokine profiles in patients with kala-azar: Marked elevation of both interleukin-10 and interferon-gamma J Clin Invest 91 1993 1644
64. F. Laguna J. Garcia-Samaniego V. Moreno Prevalence of gastrointestinal leishmaniasis in Spanish HIV-positive patients with digestive symptoms Am J Gastroenterol 89 1994 1606
65. F. Laguna J. Garcia-Samaniego V. Soriano Gastrointestinal leishmaniasis in human immunodeficiency virus-infected patients: Report of five cases and review Clin Infect Dis 19 1994 48
66. F. Laguna R. Lo´pez-Ve´lez V. Soriano Assessment of allopurinol plus meglumine antimoniate in the treatment of visceral leishmaniasis in patients infected with HIV J Infect 28 1994 255
67. S. Lamas L. Orte F. Parras Non-fatal leishmaniasis in a renal transplant recipient Nephron 45 1987 71
68. O. Lortholary D. Mechali D. Christiaens Interferon-γ associated with conventional therapy for recurrent visceral leishmaniasis in a patient with AIDS Rev Infect Dis 12 1990 370
69. A.J. Magill R.A. Gasser C.N. Oster Viscerotropic leishmaniasis in persons returning from Operation Desert Storm—1990–1991 MMWR 41 1992 131
70. A.J. Magill M. Grogl R.A. Gasser Visceral infection caused by Leishmania tropica in veterans of Operation Desert Storm N Engl J Med 328 1993 1383
71. P.E.C. Manson-Bahr East African kala-azar with special reference to the pathology, prophylaxis and treatment Trans R Soc Trop Med Hyg 53 1959 123
72. P.E.C. Manson-Bahr Immunity in kala-azar Trans R Soc Trop Med Hyg 55 1961 550
73. P.E.C. Manson-Bahr B.A. Southgate A.E.C. Harvey Development of kala-azar in man after inoculation with a Leishmania from a Kenyan sandfly BMJ 1 1963 1208
74. P.D. Marsden Selective primary health care: Strategies for control of disease in the developing world: XIV. Leishmaniasis Rev Infect Dis 6 1984 736
75. P. Marti´nez De la Vega E. F. Laguna Diagnosis of visceral leishmaniasis in HIV-infected individuals using peripheral blood smears AIDS 7 1993 227
76. M.J. McElrath H.W. Murray Z.A. Cohn The dynamics of granuloma formation in experimental visceral leishmaniasis J Exp Med 167 1988 1927
77. Y.B. Mebrahtu Van Eys G. I. Guizani Human cutaneous leishmaniasis caused by Leishmania donovani s.I. in Kenya Trans R Soc Trop Med Hyg 87 1993 598
78. F.J. Medrano J. Hernández-Quero E. Jiménez Visceral leishmaniasis in HIV-1-infected individuals: A common opportunistic infection in Spain AIDS 6 1992 1499
79. P.C. Melby R.D. Kreutzer D. McMahon-Pratt Cutaneous leishmaniasis: Review of 59 cases seen at the National Institutes of Health Clin Infect Dis 15 1992 924
80. E.A.E.R. Mohammed E.P. Wright A.M.A. Rahman Serodiagnosis of Sudanese visceral and mucosal leishmanaiasis: Comparison of ELISA-immunofluorescence and indirect haemagglutination Trans R Soc Trop Med Hyg 80 1986 271
81. H. Moll Epidermal Langerhans cells are critical for immunoregulation of cutaneous leishmaniasis Immunol Today 14 1993 383
82. H. Moll H. Fuchs C. Blank Langerhans cells transport Leishmania major from the infected skin to the draining lymph node for presentation to antigen-specific T cells Eur J Immunol 23 1993 1595
83. C. Montalban R. Martinez-Fernandez J.L. Calleja Visceral leishmaniasis (Kala-Azar) as an opportunistic infection in patients infected with the human immunodeficiency virus in Spain Rev Infect Dis 2 1989 655
84. D.M. Mosser P.J. Edelson The mouse macrophage receptor for C3bi (CR3) is a major mechanism in the phagocytosis of Leishmania promastigotes J Immunol 135 1985 2785
85. H.W. Murray M.J. Oca A.M. Granger Requirement for T-cells and effect of lymphokines in successful chemotherapy for an intracellular infection J Clin Invest 83 1989 1253
86. H.W. Murray B.Y. Rubin C.D. Rothermel Killing of intracellular Leishmania donovani by lymphokine-stimulated human mononuclear phagocytes J Clin Invest 72 1983 1506
87. H.W. Murray G.L. Spitalny C.F. Nathan Activation of mouse peritoneal macrophages in vitro and in vivo by interferon-γ J Immunol 134 1985 1619
88. H.W. Murray K.E. Squires C.D. Miralles Acquired resistance and granuloma formation in experimental visceral leishmaniasis J Immunol 148 1992 1858
89. C.F. Nathan H.W. Murray M.E. Wiebe Identification of interferon-γ as the lymphokine that activates human macrophage oxidative metabolism and antimicrobial activity J Exp Med 158 1983 670
90. S.A. Norton S. Frankenburg S.N. Klaus Cutaneous leishmaniasis acquired during military service in the Middle East Arch Dermatol 128 1992 83
91. C.A. Ohl K.C. Hyams Leishmaniasis among Desert Storm veterans: A diagnostic and therapeutic dilemma Milit Med 158 1993 726
92. P.L. Olliaro A.D.M. Bryceson Practical progress and new drugs for changing patterns of leishmaniasis Parasitol Today 9 1993 323
93. R.D. Pearson G. Cox S.M.B. Jeronimo Visceral leishmaniasis: A model for infection-induced cachexia Am J Trop Med Hyg 47 suppl 1992 8
94. R.D. Pearson Sousa Ade Q. Leishmania species: Visceral (kala-azar), cutaneous, and mucosal leishmaniasis G.L. Mandell J.E. Bennett Dolin R. Principles and Practice of Infectious Diseases ed 4 1995 Churchill Livingstone New York 2428
95. R.D. Pearson R.T. Steigbigel Mechanism of lethal effect of human serum upon Leishmania donovani J Immunol 125 1980 2195
96. R.D. Pearson R.T. Steigbigel Phagocytosis and killing of the protozoan Leishmania donovani by human polymorphonuclear leukocytes J Immunol 127 1981 1438
97. R.D. Pearson M.E. Wilson Host defenses against prototypical intracellular protozoans, the Leishmania. In Walzer P.D. Genta R.M. Parasitic Infections in the Compromised Host 1989 Marcel Dekker New York 31
98. B.S. Peters D. Fish R. Golden Visceral leishmaniasis in HIV infection and AIDS: Clinical features and response to therapy Quart J Med 283 1990 1101
99. E.A. Petersen F.A. Neva A. Barral Monocyte suppression of antigen-specific lymphocyte responses in diffuse cutaneous leishmaniasis patients from the Dominican Republic J Immunol 132 1984 2603
100. R. Piarroux F. Gambarelli H. Dumon Comparison of PCR with direct examination of bone marrow aspiration, myeloculture, and serology for diagnosis of visceral leishmaniasis in immunocompromised patients J Clin Microbiol 32 1994 746
101. C. Pirmez C. Cooper M. Paes-Oliveira Immunologic responsiveness in American cutaneous leishmaniasis lesions J Immunol 145 1990 3100
102. C. Ponce E. Ponce A. Morrison Leishmania donovani chagasi: New clinical variant of cutaneous leishmaniasis in Honduras Lancet 337 1991 67
103. J. Portoles D. Prats A. Torralbo Visceral leishmaniasis: A cause of opportunistic infection in renal transplant patients in endemic areas Transplantation 57 1994 1677
104. F. Pratlong J.P. Dedet P. Marty Leishmania –human immunodeficiency virus coinfection in the Mediterranean basin: Isoenzymatic characterization of 100 isolates of the Leishmania infantum complex J Infect Dis 172 1995 323
105. S.M. Puentes R.P. DaSilva D.L. Sacks Serum resistance of metacyclic stage Leishmania major promastigotes is due to release of C5b-9 J Immunol 145 1990 4311
106. F. Pulido R. Rubio J.R. Costa Visceral leishmaniasis as a cause of diarrhea in HIV-infected patients AIDS 9 1995 661
107. S.L. Reiner Wang Z.-E. F. Hatam Th1 and Th2 cell antigen receptors in experimental leishmaniasis Science 259 1993 1457
108. P.J. Rosenthal Rectal leishmaniasis in a patient with acquired immunodeficiency syndrome Am J Med 84 1988 307
109. D.G. Russell H. Wilhelm The involvement of the major surface glycoprotein (gp63) of Leishmania promastigotes in attachment to macrophages J Immunol 136 1986 2613
110. O.P. Sangueza J.M. Sangueza M.J. Stiller Mucocutaneous leishmaniasis: A clinicopathologic classification J Am Acad Dermatol 28 1993 927
111. P. Scott M. Wysocka T.M. Scharton IL-12 production in murine cutaneous leishmaniasis J Immunol 150 1993 86A
112. A. Sendino F.J. Barbado J.M. Mostaza Visceral leishmaniasis with malabsorption syndrome in a patient with acquired immunodeficiency syndrome Am J Med 89 1990 673
113. R. Sinha S. Sehgal Comparative evaluation of serologic tests in Indian kala-azar J Trop Med Hyg 97 1994 333
114. A.J. Smyth A. Ghosh M.Q. Hassan Rapid and sensitive detection of Leishmania kinetoplast DNA from spleen and blood samples of kala-azar patients Parasitology 105 1992 183
115. K.E. Squires R.D. Schreiber M.J. McElraith Experimental visceral leishmaniasis: Role of endogenous IFN-γ in host defense and tissue granulomatous response J Immunol 143 1989 4244
116. + cells in experimental visceral leishmaniasis J Immunol 140 1988 3971
117. Streit J.A. J.E. Donelson M.W. Agey Developmental changes in the expression of Leishmania chagasi gp63 and heat shock proteins in a human macrophage cell line Infect Immunol 1996 in press
118. S. Sundar F. Rosenkaimer H.W. Murray Successful treatment of refractory visceral leishmaniasis in India using antimony plus interferon-gamma J Infect Dis 170 1994 659
119. J. Torre-Cisneros J.L. Villaneuva J.M. Kindelan Successful treatment of antimony-resistant visceral leishmaniasis with liposomal amphotercin B in patients infected with human immunodeficiency virus Clin Infect Dis 17 1993 625
120. S.M. Vidal D. Malo K. Vogan Natural resistance to infection with intracellular parasites: Isolation of a candidate for bcg Cell 73 1993 469
121. J.P. Wali P. Aggarwal U. Gupta Ketoconazole in the treatment of antimony- and pentamidine-resistant kala-azar J Infect Dis 166 1992 215
122. J.F. Walsh D.H. Molyneux M.H. Birley Deforestation: Effects on vector-borne disease Parasitology 106 suppl 1993 S55
123. R.D. Ward Vector biology and control Chang K.-P. Bray R.S. Leishmaniasis 1985 Elsevier New York 199
124. M.E. Wilson Leishmaniasis Curr Opin Infect Dis 3 1990 420
125. M.E. Wilson K.K. Hardin The major concanavalin A–binding surface glycoprotein of Leishmania donovani chagasi promastigotes is involved in attachment to human macrophages J Immunol 141 1988 265
126. M.E. Wilson R.D. Pearson Evidence that Leishmania donovani utilizes a mannose receptor on human mononuclear phagocytes to establish intracellular parasitism J Immunol 136 1986 4681
127. M.E. Wilson R.D. Pearson Roles of CR3 and mannose receptors in the attachment and ingestion of Leishmania donovani by human mononuclear phagocytes Infect Immunol 56 1988 363
128. A.O. Wozencraft G. Sayers J.M. Blackwell Macrophage type 3 complement receptors mediate serum-independent binding of Leishmania donovani: Detection of macrophage-derived complement on the parasite surface by immunoelectron microscopy J Exp Med 164 1986 1332
129. S.D. Wright S.C. Silverstein Receptors for C3b and C3bi promote phagocytosis but not the release of toxic oxygen from human phagocytes J Exp Med 158 1983 2016
130. D.J. Wyler J.P. Sypek J.A. McDonald In vitro parasite-monocyte interactions in human leishmaniasis: Possible role of fibronectin in parasite attachment Infect Immunol 49 1985 305
131. E.E. Zijlstra M.S. Ali A.M. El-Hassan Clinical aspects of kala-azar in children from the Sudan: A comparison with the disease in adults J Trop Pediatr 38 1992 17
132. E.E. Zijlstra A.M. El-Hassan Leishmanin and tuberculin sensitivity in leishmaniasis in the Sudan, with special reference to kala-azar Trans R Soc Trop Med Hyg 87 1993 425